Last reviewed · How we verify

NCT05323175

Erector Spinae Plane (ESP) Block for Renal Colic

Active, enrolled Phase 4 Last updated 27 January 2025
What this trial tests

Phase 4 trial testing Ropivacaine injection in Renal Colic in 24 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
25 April 2022
Primary endpoint
1 June 2024
1 June 2025

Quick facts

Lead sponsorStony Brook University
PhasePhase 4
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment24
Start date25 April 2022
Primary completion1 June 2024
Estimated completion1 June 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stony Brook University

Who can join

Adults 18 to 65, any sex, with Renal Colic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparing standard of care to erector spinae plane block for acute renal colic pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ropivacaine injection

Trials testing the same drug.

Other recruiting trials for Renal Colic

Currently open trials in the same condition.

Other Stony Brook University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05323175.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing